This week’s newsletter covers the latest in plant medicine research, including how cannabinoid chirality affects therapeutic potential, psychedelics promoting brain plasticity, psilocybin-assisted therapy for cancer patients, CBD’s effects on gut health and arthritis, cannabinoids for nerve pain, endocannabinoids and cardiovascular disease, and a broad overview of CBD’s clinical applications.
Noteworthy Read
Have you ever wondered why certain cannabis compounds work differently, even though they seem so similar? It all comes down to chirality, the 3D structure of these molecules. This study dives into how the “mirror image” versions of cannabinoids affect how they interact with our bodies, from binding to receptors to influencing therapeutic effects. Understanding these differences could help create safer, more effective cannabis-based medicines.
For a broader understanding of cannabinoid chirality and its implications, see this Project CBD article published in 2022.
Research Round-Up
Psychedelic-Induced Neuroplasticity (NaturePortfolio)
A study explores how psychedelics promote neuroplasticity, enhancing brain connectivity and potentially supporting treatments for depression and other mental health disorders. Read more
View more in Psychedelics
Psilocybin Therapy for Cancer Patients (PsyPost)
Research shows that psilocybin-assisted therapy provides significant relief from depression, anxiety, and other psychiatric symptoms in cancer patients, supporting its use as a palliative care option. “>Read more
View more in Psychedelics
CBD Modulates Gut Microbiota to Ameliorate Arthritis (Phytomedicine)
A study reveals that CBD improves gut microbiota balance, reducing inflammation and arthritis symptoms, showcasing its potential for managing chronic inflammatory conditions. Read more
View more in CBD
Cannabinoids for Treating Peripheral Neuropathy (PubMed)
A review highlights cannabinoids’ effectiveness in relieving chronic nerve pain associated with peripheral neuropathy, with fewer side effects than conventional treatments. Read more
View more in Endocannabinoid System
Endocannabinoids & Atherosclerosis (Cardiology Plus)
This review discusses how endocannabinoids influence cardiovascular health, presenting opportunities for cannabinoid-based therapies in managing atherosclerosis. Read more
View more in Endocannabinoid System
Research & Clinical Practice Involving CBD (MDPI)
A comprehensive overview of recent CBD studies highlights its broad therapeutic applications, ranging from epilepsy to mental health, while emphasizing gaps in clinical research. Read more
View more in CBD
A heartfelt thank you to all of the CBD brands whose generous support makes it possible for Project CBD to bring you the latest and most important developments in plant medicine research each week. We couldn’t do this work without you.
